Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 4
2018 7
2019 4
2020 2
2021 7
2022 9
2023 8
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.
de Mendoza C, Rando A, Miró E, Pena MJ, Rodríguez-Avial I, Ortega D, González-Praetorius A, Reina G, Pintos I, Pozuelo MJ, Soriano V; Spanish HTLV Network. de Mendoza C, et al. J Clin Virol. 2023 Oct;167:105578. doi: 10.1016/j.jcv.2023.105578. Epub 2023 Aug 28. J Clin Virol. 2023. PMID: 37660433
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin.
Fayos M, Silva JT, Fernández-Ruiz M, Ruiz-Merlo T, Visentin A, Loinaz C, Manrique-Municio A, Caso JM, González-Olmedo J, Rodríguez-Góncer I, López-Medrano F, Lumbreras C, Aguado JM, San-Juan R. Fayos M, et al. Among authors: ruiz merlo t. Transpl Infect Dis. 2024 Dec;26(6):e14382. doi: 10.1111/tid.14382. Epub 2024 Sep 28. Transpl Infect Dis. 2024. PMID: 39340395
Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients.
Fernández-Ruiz M, Nuévalos M, Rodríguez-Goncer I, García-Ríos E, Ruiz-Merlo T, Redondo N, Trujillo H, González E, Polanco N, Caso JM, Aparicio-Minguijón E, López-Medrano F, San Juan R, Andrés A, Pérez-Romero P, Aguado JM. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Transpl Infect Dis. 2025 Jan 10:e14437. doi: 10.1111/tid.14437. Online ahead of print. Transpl Infect Dis. 2025. PMID: 39791950
SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19.
Fernández-Ruiz M, Olea B, Giménez E, Laguna-Goya R, Trujillo H, Caravaca-Fontán F, Gutiérrez E, López-Medrano F, Remigia MJ, Almendro-Vazquez P, Polanco N, González E, Ruiz-Merlo T, Parra P, San Juan R, Andrés A, Navarro D, Aguado JM. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Transplantation. 2021 Jun 1;105(6):1372-1380. doi: 10.1097/TP.0000000000003672. Transplantation. 2021. PMID: 33729741
T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.
Fernández-Ruiz M, Olea B, Almendro-Vázquez P, Giménez E, Marcacuzco A, San Juan R, Justo I, Calvo-Pulido J, García-Sesma Á, Manrique A, Caso O, Cambra F, Talayero P, López-Medrano F, Remigia MJ, Ruiz-Merlo T, Parra P, Paz-Artal E, Jiménez C, Loinaz C, Navarro D, Laguna-Goya R, Aguado JM. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Am J Transplant. 2021 Aug;21(8):2785-2794. doi: 10.1111/ajt.16708. Epub 2021 Jun 25. Am J Transplant. 2021. PMID: 34092033 Free PMC article.
Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation.
Fernández-Ruiz M, López-García Á, Valverde-Manso A, Parra P, Rodríguez-Goncer I, Ruiz-Merlo T, López-Medrano F, González E, Polanco N, San Juan R, Andrés A, Aguado JM, Redondo N. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Am J Transplant. 2024 Jul;24(7):1180-1192. doi: 10.1016/j.ajt.2024.01.028. Epub 2024 Feb 2. Am J Transplant. 2024. PMID: 38311311 Free article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Med Clin (Engl Ed). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcle.2021.06.025. Epub 2022 Jun 22. Med Clin (Engl Ed). 2022. PMID: 35761980 Free PMC article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: ruiz merlo t. Med Clin (Barc). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcli.2021.06.014. Epub 2021 Jun 18. Med Clin (Barc). 2022. PMID: 34243954 Free PMC article.
49 results